Genetic Variations of HLA-DRB1 and Susceptibility to Kawasaki Disease in Taiwanese Children

Human Immunology

Volumn 68, Issue 1, 2007, Pages 69-74

  Huang, Fu Yuan ^a,b   Chang, Tzu Yang ^a   Chen, Ming Ren ^a,c   Hsu, Chyong Hsin ^a   Lee, Hung Chang ^a,b   Lin, Shuan Pei ^a,c   Kao, Hsin An ^a,b   Chiu, Nan Chang ^a   Chi, Hsin ^a   Liu, Tiffany Yi Chen ^a   Liu, Hsin Fu ^a   Dang, Ching Wen ^a   Chu, Chen Chung ^a   Lin, Marie ^a   Sung, Tseng Chen ^d   Lee, Yann Jinn ^a,b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

coronary artery lesion; immunogenetics; Kawasaki Disease; polymorphism; Taiwanese

Indexed keywords

GENOMIC DNA; HLA DR ANTIGEN;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOGENETICS; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TAIWAN;

CHILD; CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; TAIWAN; VARIATION (GENETICS);

EID: 33845912932     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.10.018     Document Type: Article

References (45)

1. Laupland K.B., and Dele Davies H. Epidemiology, etiology, and management of Kawasaki disease: state of the art. Pediatr Cardiol 20 (1999) 177
2. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., and Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54 (1974) 271
3. Dajani A.S., Taubert K.A., Gerber M.A., Shulman S.T., Ferrieri P., Freed M., Takahashi M., Bierman F.Z., Karchmer A.W., Wilson W., Rahimtoola S.H., Durack D.T., and Peter G. Diagnosis and therapy of Kawasaki disease in children. Circulation 87 (1993) 1776
4. Taubert K.A., Rowley A.H., and Shulman S.T. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119 (1991) 279
5. Yanagawa H., Nakamura Y., Yashiro M., Fujita Y., Nagai M., Kawasaki T., Aso S., Imada Y., and Shigematsu I. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 158 (1988) 1296
6. Morens D.M., Anderson L.J., and Hurwitz E.S. National surveillance of Kawasaki disease. Pediatrics 65 (1980) 21
7. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 53 (1997) 1
8. Singh N., Agrawal S., and Rastogi A.K. Infectious diseases and immunity: special reference to major histocompatibility complex. Emerg Infect Dis 3 (1997) 41
9. Hill A.V. The immunogenetics of human infectious diseases. Annu Rev Immunol 16 (1998) 593
10. Matsuda I., Hattori S., Nagata N., Fruse A., and Nambu H. HLA antigens in mucocutaneous lymph node syndrome. Am J Dis Child 131 (1977) 1417
11. Kato S., Kimura M., Tsuji K., Kusakawa S., Asai T., Juji T., and Kawasaki T. HLA antigens in Kawasaki disease. Pediatrics 61 (1978) 252
12. Keren G., Danon Y.L., Orgad S., Kalt R., and Gazit E. HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients. Tissue Antigens 20 (1982) 144
13. Krensky A.M., Berenberg W., Shanley K., and Yunis E.J. HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics 67 (1981) 741
14. Krensky A.M., Grady S., Shanley K.M., Berenberg W., and Yunis E.J. Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. Hum Immunol 6 (1983) 75
15. Kaslow R.A., Bailowitz A., Lin F.Y., Koslowe P., Simonis T., and Israel E. Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination. Arthritis Rheum 28 (1985) 938
16. Maclaren N., and Skordis N. Is Kawasaki HLA associated?. Prog Clin Biol Res 250 (1987) 475
17. Chang C.C., Hawkins B.R., Kao H.K., Chow C.B., and Lau Y.L. Human leucocyte antigens in southern Chinese with Kawasaki disease. Eur J Pediatr 151 (1992) 866
18. Barron K.S., Silverman E.D., Gonzales J.C., St Clair M., Anderson K., and Reveille J.D. Major histocompatibility complex class II alleles in Kawasaki syndrome-lack of consistent correlation with disease or cardiac involvement. J Rheumatol 19 (1992) 1790
19. Fildes N., Burns J.C., Newburger J.W., Klitz W., and Begovich A.B. The HLA class II region and susceptibility to Kawasaki disease. Tissue Antigens 39 (1992) 99
20. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., Shulman S.T., Bolger A.F., Ferrieri P., Baltimore R.S., Wilson W.R., Baddour L.M., Levison M.E., Pallasch T.J., Falace D.A., and Taubert K.A. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110 (2004) 2747
21. Arjunan K., Daniels S.R., Meyer R.A., Schwartz D.C., Barron H., and Kaplan S. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. J Am Coll Cardiol 8 (1986) 1119
22. Lee H.H., Chao H.T., Ng H.T., and Choo K.B. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 33 (1996) 371
23. Chu C.C., Lin M., Nakajima F., Lee H.L., Chang S.L., Juji T., and Tokunaga K. Diversity of HLA among Taiwan's indigenous tribes and the Ivatans in the Philippines. Tissue Antigens 58 (2001) 9
24. Voorter C.E., Rozemuller E.H., de Bruyn-Geraets D., van der Zwan A.W., Tilanus M.G., and van den Berg-Loonen E.M. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens 49 (1997) 471
25. Lancaster A., Nelson M.P., Meyer D., Thomson G., and Single R.M. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pac Symp Biocomput 8 (2003) 514
26. Guo S.W., and Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48 (1992) 361
27. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251
28. Haldane J.B. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20 (1956) 309
29. Svejgaard A., Jersild C., Nielsen L.S., and Bodmer W.F. HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens 4 (1974) 95
30. Svejgaard A., and Ryder L.P. HLA and disease associations: detecting the strongest association. Tissue Antigens 43 (1994) 18
31. Ohashi J., Yamamoto S., Tsuchiya N., Hatta Y., Komata T., Matsushita M., and Tokunaga K. Comparison of statistical power between 2 * 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet 65 (2001) 197
32. Chang L.Y., Chang I.S., Lu C.Y., Chiang B.L., Lee C.Y., Chen P.J., Wang J.T., Ho H.N., Chen D.S., Huang L.M., and Kawasaki Disease Research Group. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics 114 (2004) e678
33. Fujita Y., Nakamura Y., Sakata K., Hara N., Kobayashi M., Nagai M., Yanagawa H., and Kawasaki T. Kawasaki disease in families. Pediatrics 84 (1989) 666
34. Wu S.F., Chang J.S., Peng C.T., Shi Y.R., and Tsai F.J. Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 25 (2004) 529
35. Onouchi Y., Onoue S., Tamari M., Wakui K., Fukushima Y., Yashiro M., Nakamura Y., Yanagawa H., Kishi F., Ouchi K., Terai M., Hamamoto K., Kudo F., Aotsuka H., Sato Y., Nariai A., Kaburagi Y., Miura M., Saji T., Kawasaki T., Nakamura Y., and Hata A. CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 12 (2004) 1062
36. Nishimura S., Zaitsu M., Hara M., Yokota G., Watanabe M., Ueda Y., Imayoshi M., Ishii E., Tasaki H., and Hamasaki Y. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143 (2003) 357
37. Sohn M.H., Hur M.W., and Kim D.S. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2 (2001) 357
38. Quasney M.W., Bronstein D.E., Cantor R.M., Zhang Q., Stroupe C., Shike H., Bastian J.F., Matsubara T., Fujiwara M., Akimoto K., Newburger J.W., and Burns J.C. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 49 (2001) 686
39. Gambelunghe G., Falorni A., Ghaderi M., Laureti S., Tortoioli C., Santeusanio F., Brunetti P., and Sanjeevi C.B. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab 84 (1999) 3701
40. Gotch F., Gallimore A., and McMichael A. Cytotoxic T cells-protection from disease progression-protection from infection. Immunol Lett 51 (1996) 125
41. Barron K., DeCunto C., Montalvo J., Orson F., and Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 15 (1988) 1243
42. Terai M., Kohno Y., Namba M., Umemiya T., Niwa K., Nakajima H., and Mikata A. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 21 (1990) 231
43. Leung D.Y., Siegel R.L., Grady S., Krensky A., Meade R., Reinherz E.L., and Geha R.S. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol 23 (1982) 100
44. Laxer R.M., Schaffer F.M., Myones B.L., Yount W.J., Rowe R.D., Rubin L., Stein L.D., Gelfand E.W., and Silverman E.D. Lymphocyte abnormalities and complement activation in Kawasaki disease. Prog Clin Biol Res 250 (1987) 175
45. Jason J., Gregg L., Han A., Hu A., Inge K.L., Eick A., Tham I., and Campbell R. Immunoregulatory changes in Kawasaki disease. Clin Immunol Immunopathol 84 (1997) 296